marimastat has been researched along with thiazoles in 1 studies
| Studies (marimastat) | Trials (marimastat) | Recent Studies (post-2010) (marimastat) | Studies (thiazoles) | Trials (thiazoles) | Recent Studies (post-2010) (thiazoles) |
|---|---|---|---|---|---|
| 215 | 28 | 53 | 33,179 | 2,100 | 12,330 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujii, M; Igarashi, N; Kameyama, K; Kimata, M; Kitajima, M; Kubota, T; Kumai, K; Okada, Y; Otani, Y; Wada, N; Yokoyama, T; Yoshimizu, N | 1 |
1 other study(ies) available for marimastat and thiazoles
| Article | Year |
|---|---|
Matrix metalloproteinase inhibitor, marimastat, decreases peritoneal spread of gastric carcinoma in nude mice.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Body Weight; Cell Survival; Coloring Agents; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Hydroxamic Acids; Male; Matrix Metalloproteinase Inhibitors; Mice; Mice, Inbred BALB C; Mice, Nude; Mitomycin; Models, Chemical; Neoplasm Metastasis; Neoplasm Transplantation; Peritoneum; Stomach Neoplasms; Tetrazolium Salts; Thiazoles; Time Factors; Tumor Cells, Cultured | 2002 |